Be part of the knowledge

Medical News

miragenews.com
05/13/2022
Medical News
Modifying the Body’s Immune System to Help Treat Type 1 Diabetes
Read more
medicalxpress.com
05/13/2022
Medical News
Over 7 Million Europeans Estimated to Have Skin Cancer, Despite 'Majority of Ca…
Read more
news.weill.cornell.edu
05/13/2022
Medical News
Dr. Denise Howard Named Chief of Obstetrics and Gynecology at NewYork-Presbyter…
Read more

See more news

- Marco Metra, MD
  Peer
- Adrian F. Hernandez, MD, MHS
  Peer
3
Global Heart Failure Academy
From Paper to Patient: Applying Guideline Updates to Practice
From Paper to Patient: Applying Guideline Updates to Practice
From Paper to Patient: Applying Guideline Updates to Practice
- Ahmad Masri, MD, MS
  Peer
- Steve R. Ommen, MD
  Peer
5
CME/CE
Hypertrophic Cardiomyopathy: The 3 Things You Need to Know
Hypertrophic Cardiomyopathy: The 3 Things You Need to Know
0.25 credits
Hypertrophic Cardiomyopathy: The 3 Things You Need to Know
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Stefan D. Anker, MD, PhD
  Peer
14
CME/CE
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
0.25 credits
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Toplin…
0.25 credits
- George L. Bakris, MD
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
3
CME/CE
Optimizing RAASi Therapy: The Role of Personalized Medicine
Optimizing RAASi Therapy: The Role of Personalized Medicine
0.25 credits
Optimizing RAASi Therapy: The Role of Personalized Medicine
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Javed Butler, MD, MBA, MPH
  Peer
- Matthew R. Weir, MD
  Peer
4
CME/CE
Synergy of Guideline-Directed Medical Therapies in Heart Failure to Optimize Patient Outcomes
Synergy of Guideline-Directed Medical Therapies in Heart Failure to Optimize Patient Outcomes
0.50 credits
Synergy of Guideline-Directed Medical Therapies in Heart Failure to Optimize Pa…
0.50 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Piotr Ponikowski, MD, PHD, FESC, FHFA
  Peer
5
Global Heart Failure Academy
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart Failure
Clinical Implications of ESC/HFA Guideline Updates for Iron Deficiency in Heart…
- Keith C. Ferdinand, MD
  Peer
- Marco Metra, MD
  Peer
9
CME/CE
Managing HK in HF: Navigating the Evolving Clinical Landscape
Managing HK in HF: Navigating the Evolving Clinical Landscape
0.25 credits
Managing HK in HF: Navigating the Evolving Clinical Landscape
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Ewa A. Jankowska, MD, PhD, FESC
  Peer
- Phil McEwan, PhD
  Peer
4
CME/CE
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeconomic Impact
0.25 credits
Making the Case for Iron Replacement Therapy in HFrEF: Clinical and Pharmacoeco…
0.25 credits

Featured

- Mark J. Alberts, MD
  Peer
- Matthew Jay Budoff, MD
  Peer
- Lawrence A. Leiter, MD
  Peer
5
CME/CE
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease
0.75 credits
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease
0.75 credits
- Peter Libby, MD
  Peer
- Lawrence A. Leiter, MD
  Peer
- Prof. Kausik Ray, MBChB, MD, MPhil
  Peer
5
CME/CE
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction
0.25 credits
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASC…
0.25 credits
- Peter Rossing, DMSc, MD
  Peer
- Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
  Peer
- Matthew R. Weir, MD
  Peer
10
CME/CE
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
0.25 credits
New Insights into the Management of CKD in T2D: The Role of MRA Therapies
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
  Peer
9
CME/CE
New Perspectives in Managing HF and HK – The Cardiorenal Angle
New Perspectives in Managing HF and HK – The Cardiorenal Angle
0.25 credits
New Perspectives in Managing HF and HK – The Cardiorenal Angle
0.25 credits